# The Effect of Dapagliflozin on Ultrafiltration Among Peritoneal Dialysis Patients

> **NCT04923295** · NA · COMPLETED · sponsor: **An-Najah National University** · enrollment: 20 (actual)

## Conditions studied

- Peritoneal Dialysis Complication
- Ultrafiltration Failure

## Interventions

- **DRUG:** Dapagliflozin 10Mg Tab

## Key facts

- **NCT ID:** NCT04923295
- **Lead sponsor:** An-Najah National University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-02
- **Primary completion:** 2021-07-28
- **Final completion:** 2021-07-28
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04923295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04923295, "The Effect of Dapagliflozin on Ultrafiltration Among Peritoneal Dialysis Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04923295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*